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Abstract
We recently reported that there was enhanced cyclooxygenase (COX)-2 expression and prostaglandin E2 biosynthesis in
COX-1 deficient (COX-13=3) cells. We also observed that the growth of COX-13=3 cells was significantly retarded compared
to wild-type (WT) and COX-2 deficient (COX-23=3) cells. In this study, COX-2 expression and its promoter activity were
compared in immortalized, nontransformed fibroblasts from WT, COX-13=3 or COX-23=3 mice in the context of the role of
COX-2 as a growth regulator. When compared with WT cells expressing both COX isoenzymes, constitutive COX-2 protein
and promoter activity were significantly higher in COX-13=3 cells as determined by Western blotting and luciferase assays
using a 5P-flanking promoter construct of the murine COX-2 gene. The luciferase assay using a series of luciferase-linked
COX-2 promoter deletions transfected into COX-13=3 cells indicated that a region involving NF-UB plays a significant role
in regulating constitutive COX-2 expression. Data from electrophoretic mobility shift assays showed that COX-13=3 cells
contained higher levels of activated NF-UB than either WT or COX-23=3 cells. Furthermore, COX-2 promoter activity was
significantly inhibited by the oligonucleotides (ODNs) containing the NF-UB element (NF-UB decoy ODNs) but not by the
scrambled control ODNs, as examined by the luciferase assay. These findings indicate that constitutive COX-2 promoter
activity and protein expression are enhanced in COX-13=3 fibroblasts and that signaling via the NF-UB pathway is involved
in the transcriptional control of constitutive COX-2 expression. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The conversion of arachidonic acid (AA) to pros-
taglandin (PG) H2, the committed step in prostanoid
biosynthesis, is catalyzed by the cyclooxygenase
(COX) isoenzymes, COX-1 and COX-2, each of
which is encoded by a unique gene, located on di¡er-
ent chromosomes [1]. Since the discovery of COX-2,
many studies have been carried out in an e¡ort to
distinguish between the precise biological roles of the
COX isoenzymes in normal and pathophysiological
circumstances.
COX-1 is constitutively expressed in most tissues
and thought to primarily perform ‘housekeeping’
functions, such as gastric cytoprotection, regulation
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of renal blood £ow, and platelet aggregation [2^4]. In
contrast, COX-2 mRNA and protein are normally
undetectable in most tissues, but it can be rapidly
expressed in response to a wide variety of extracellu-
lar stimuli as part of the in£ammatory response [1,5].
In addition to its association with in£ammation,
COX-2 expression clearly plays a role in regulating
cellular proliferation and di¡erentiation [6^9]. In-
creased COX-2 expression has also been shown in
human colorectal adenocarcinomas [10^12], and in
this context, increased COX-2 expression causes a
delay in G1 and thus inhibits rat intestinal epithelial
cell growth [13,14].
Despite intense investigations, the precise roles and
relative contributions of the COX isoenzymes in a
variety of pathophysiological processes are not en-
tirely clear. Most of the current knowledge has
been provided by the use of selective COX-1 or
COX-2 inhibitors or the overexpression of COX-1
or COX-2. As an alternative approach, COX-1
(COX-13=3) or COX-2 (COX-23=3) de¢cient mice
generated by gene targeting have provided more de-
¢nitive information about the individual roles and
interactions of the two COX isoenzymes [15,16].
We recently examined the e¡ects of COX de¢ciency
using COX-13=3 and COX-23=3 cells and reported
that COX-2 expression and prostaglandin E2 biosyn-
thesis was greatly enhanced in COX-13=3 ¢broblasts
derived from the lung of the COX-1 de¢cient mice
[17]. The purpose of the present study was to inves-
tigate the transcriptional regulatory mechanism in-
volved in the constitutive overexpression of COX-2
in COX-13=3 ¢broblasts and determine the e¡ects of
COX-2 expression on cell growth.
2. Materials and methods
2.1. Preparation and culture of COX de¢cient mouse
cells
Tails were collected from wild-type (WT) Black 6
(C57BL/6, B6), COX-1 de¢cient [15] and COX-2 de-
¢cient [16] mice. The tissues were dissected into small
pieces and grown under coverslips in 10 cm tissue
culture dishes with Eagle’s minimum essential me-
dium (MEM). Cells were supplemented with
300 000 units/l of penicillin G, 300 mg/l streptomycin,
1 mg/l of fungizone, 0.1 mM of nonessential amino
acids, 292 mg/l of glutamine, 50 mg/l of ascorbic acid
and 10% fetal calf serum (FCS) in a humidi¢ed in-
cubator with 5% CO2, and the media were changed
three times per week. After 3 weeks, the concentra-
tion of penicillin G and streptomycin were reduced
to 100 000 units/l and 100 mg/l, respectively and cells
were incubated for another 3^5 weeks. During sub-
sequent passages, cells were maintained in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) containing
high glucose and supplemented with 100 000 units/l
of penicillin G, 100 mg/l streptomycin, 1 mg/l of
fungizone, 0.1 mM of nonessential amino acids,
292 mg/l of glutamine, 50 mg/l of ascorbic acid and
10% FCS.
2.2. Immortalization of COX de¢cient cells
Immortalized COX de¢cient tail cells were pre-
pared as described previously [17]. Subcon£uent
monolayers of COX-13=3 or COX-23=3 tail ¢bro-
blasts (passages 5^7) were cotransfected with 8 Wg/
dish of pLE12S plasmid containing adenovirus E1A
gene and 2 Wg/dish of pREP4 plasmid containing
hygromycin resistance gene (Invitrogen, Carlsbad,
CA, USA) using the LipofectAMINE reagent (Gibco
BRL, Gaithersburg, MD, USA). pLE12S plasmid
was kindly provided by Dr. Margaret Quinlan (Uni-
versity of Tennessee, Memphis, TN, USA). Cells
were maintained in the above media containing 50
Wg/ml hygromycin for 1 week. Hygromycin in the
culture media was increased by 50 Wg/ml per week
until the ¢nal concentration reached 250 Wg/ml. Sub-
sequent cell passage and subculture were done in
media containing 250 Wg/ml hygromycin.
2.3. Cell growth assays
Viable cell growth was monitored by MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay [18]. Cells were plated at 1U104 into
96-well plates. At the indicated times (culture days),
10 Wl of MTT (5 mg/ml in PBS) was added to each
well and plates were incubated at 37‡C for 4 h. Acid-
isopropanol (100 Wl of 0.04 N HCl in isopropanol)
was added to all wells and mixed thoroughly to dis-
solve the dark blue crystals. Plates were placed at
room temperature overnight, blocking light, to en-
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sure that all crystals were dissolved and read on a
Dynatech MR600 Microplate Reader, using a test
wave length of 570 nm, a reference wavelength of
630 nm, and a calibration setting of 1.99.
2.4. Cell cycle analysis
Cells suspended in DMEM with 10% FCS were
seeded in 10 cm plates at 1U106/plate. The next
day, at 60^70% con£uence, cells were placed in
DMEM with 0.5% FCS for 48 h to arrest them at
the G1/S boundary. Then the cells were exposed to
DMEM containing 10% FCS. After various times
following stimulation of quiescent cells, £ow cyto-
metric DNA analyses were carried out as described
[19] with some modi¢cations. Cells were rinsed twice
by PBS, trypsinized in 3 ml of 0.25% trypsin/0.02%
EDTA for 2 min, and centrifuged at 200Ug for
5 min. The pelleted cells were washed twice in PBS
by centrifugation (200Ug for 5 min), resuspended in
1 ml of PBS, and then ¢xed with 2 ml of 70% ethanol
(320‡C) at room temperature for 30 min. They were
again washed in PBS by centrifugation and the
washed pellet was treated by 1 ml of RNase A (100
Wg/ml in PBS) at 37‡C for 30 min. The cells were
pelleted by centrifugation and 1 ml of propidium
iodide (5 Wg/ml in PBS) was added to stain DNA.
The cells were incubated at room temperature for
20^30 min in the dark, and analyzed for DNA con-
tent using an Epics Pro¢ler II (Coulter Electronics,
Fullerton, CA, USA) with an argon laser emitting
at 488 nm. Percentages of cells in various phases of
the cell cycle were determined using the ‘multi-cycle’
program (Phoenix Flow Systems, San Diego, CA,
USA).
2.5. Western blotting
WT, COX-13=3, and COX-23=3 tail ¢broblasts
grown in 10 cm plates were pelleted in PBS contain-
ing 1 Wg/ml leupeptin, 0.03% aprotinin, 2 mM phen-
ylmethylsulfonyl £uoride (PMSF), and 2 mM
EDTA, pH 7.2. Proteins were obtained by resus-
pending the pellet in extraction bu¡er (62.5 mM
Tris, pH 6.8, 2% SDS, and freshly added 0.5 mM
dithiothreitol (DTT) and 1 mM PMSF) and denatur-
ing the proteins by placing the sample test tubes at
95‡C for 5 min. Identical amounts of protein were
electrophoresed in a 7.5% SDS/polyacrylamide gel
and transferred to a polyvinylidene di£uoride
(PVDF) membrane. The membrane was blocked
with 5% non-fat dry milk in Tris-bu¡ered saline
with 0.1% Tween 20 and incubated with a rabbit
antibody against murine COX-2 (Cayman Chemical,
Ann Arbor, MI, USA). Then immunoreactive bands
were detected using an ECL kit (Amersham, Prince-
ton, NJ, USA).
2.6. Construction of mouse COX-2 promoter gene and
luciferase reporter vectors
The plasmid containing the 5P-£anking region of
the mouse COX-2 gene was a gift from Dr. Nicolas
G. Bazan (Louisiana State University, New Orleans,
LA, USA). DNA fragments of mouse COX-2 pro-
moter regions of various lengths covering the region
to 3887, 3368, 3223, 3207, 3141 and 3130 bp
were prepared by polymerase chain reaction (PCR)
and inserted into the pGL2 plasmid vector (Promega,
Madison, WI, USA).
2.7. Transient transfections and luciferase assay
WT, COX-13=3, and COX-23=3 tail ¢broblasts
were seeded at 105=well into six-well tissue culture
dishes 1 day prior to transfection. Transfection was
carried out using LipofectAMINE according to the
manufacturer’s instructions. 2.4 Wl of LipofectAM-
INE and 1 Wg of plasmid DNA were diluted individ-
ually in 300 Wl aliquots of OptiMEM I reduced-
serum medium (Gibco BRL). Cells were incubated
with DNA lipid complexes for 5 h and then fed
DMEM containing 10% FCS; 24^30 h after trans-
fection, cells were rinsed and harvested in PBS
and lysed in 100 Wl of 1Ucell culture lysis reagent
(Promega). Aliquots of cell extracts were mixed
with 100 Wl of 470 mM luciferin and light intensity
was measured in a Turner Designs Luminometer
Model 20. Expression of luciferase in cells trans-
fected with pGL2-Basic vector which lacks eukary-
otic promoter and enhancer and pGL2-Control vec-
tor which contains SV40 promoter and enhancer was
used as negative and positive control, respectively.
The variable transfection e⁄ciencies were corrected
by expression of the cotransfected pSV-L-galactosi-
dase plasmid.
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2.8. NF-UB decoy oligonucleotide (ODN) treatment
Phosphorothioated and double-stranded 20 bp
NF-UB decoy ODNs (5P-CCTTGAAGGGATTT-
CCCTCC-3P) and scrambled ODNs (5P-TTGCCG-
TACCTGACTTAGCC-3P) were synthesized accord-
ing to the previous report [20]. To study the e¡ect of
the NF-UB decoy ODNs, COX-13=3 cells transfected
with an 887 nucleotide luciferase reporter construct
of the COX-2 promoter region were used. After the
promoter reporter construct was transfected, 10 WM
NF-UB decoy or scrambled ODNs were added to
fresh DMEM containing 10% FCS. Cells were incu-
bated for 24 h and examined for luciferase activities.
2.9. Preparation of nuclear extracts
Nuclear extracts were prepared according to the
published methods [21,22]. Cells grown in three 10
cm plates were rinsed and scraped in PBS, resus-
pended in hypotonic bu¡er (10 mM HEPES, 1.5
mM MgCl2, 10 mM KCl, 0.2 mM PMSF, 0.5 mM
DTT), and homogenized. The nuclei were collected
by centrifugation for 15 min at 3300Ug and resus-
pended in low-salt bu¡er (20 mM HEPES, 25% glyc-
erol, 1.5 mM MgCl2, 20 mM KCl, 0.2 mM PMSF,
0.5 mM DTT). The salt concentration of the nuclear
suspension was adjusted to 0.6 M KCl that released
soluble nuclear proteins. Nuclei were then pelleted by
centrifugation for 30 min at 25 000Ug and the pro-
tein extracts were dialyzed against a bu¡er contain-
ing 100 mM KCl. The precipitated protein was re-
moved by centrifugation for 20 min at 25 000Ug and
the supernatant fractions were stored in aliquots at
380‡C until analysis.
2.10. Electrophoretic mobility shift assay
Compensatory single-stranded oligonucleotides
containing the NF-UB (5P-GGGAGAGGTGAGGG-
GATTCCCTTAGTTAGG-3P) transcriptional ele-
ment with four nucleotide-long 5P-guanine overhang
were annealed and radiolabeled by end ¢lling with
Klenow fragment using [K-32P]dCTP. The labeled
DNA probes were incubated with nuclear extracts
at room temperature for 30 min. The incubation
mixture contained 10 000 cpm/Wl of DNA probe, 10
Wg of nuclear extracts, 5 Wg of poly(dI-dC), and 7.5
Wg of bovine serum albumin, and was adjusted to a
¢nal volume of 25 Wl by incubation bu¡er (20 mM
HEPES, pH 7.9, 20% glycerol, 100 mM KCl, 0.2
mM EDTA, 0.2 mM PMSF, and 0.5 mM DTT).
For supershift experiments, 2 Wg of antiserum specif-
ic for the p50 or p65 subunit of the NF-UB complex
(Santa Cruz Biotechnology, Santa Cruz, CA, USA)
were added to the mixture. The contents of the bind-
ing reactions were electrophoresed on a nondenatur-
ing 6% polyacrylamide gel at 4‡C. Gels were dried
under vacuum followed by autoradiography.
2.11. Statistical analysis
Paired t-test was used to determine the di¡erences
in cell growth and promoter activity between WT
and COX-13=3 cells.
3. Results and discussion
3.1. Growth retardation and G1 delay in
COX-13=3 cells
Since COX-2 has been demonstrated to play a role
in regulating cellular growth [6,7,9], we carried out
cell growth and cell cycle analysis of WT, COX-
13=3, and COX-2 3=3 cells. As shown in Fig. 1,
growth of COX-13=3 cells was signi¢cantly retarded
compared to WT and COX-2 3=3 cells as determined
by MTT assay (Fig. 1). COX-13=3 cells had the least
percentage of cells in S-phase at 8 h and 24 h after
arresting the cells at the G1/S boundary (Fig. 2A,B).
Previous studies using rat intestinal epithelial cells
demonstrated that COX-2 overexpression resulted
in G1 delay and consequent growth inhibition
[13,14]. This observation raised the possibility that
growth retardation and G1 delay observed in our
COX-13=3 cells was due to the increased constitutive
expression of COX-2 in these cells.
3.2. Constitutive COX-2 protein expression is
increased in COX-13=3 cells
We analyzed constitutive COX-2 protein expres-
sion in WT, COX-13=3 and COX-23=3 ¢broblasts.
As shown in Fig. 3, the amount of COX-2 protein
constitutively expressed in COX-13=3 cells was sig-
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ni¢cantly elevated when compared with WT cells. As
expected there was no COX-2 protein in COX-23=3
cells. This result was consistent with our recent re-
port describing that constitutive and inducible levels
of COX-2 protein as well as constitutive and induc-
ible PGE2 production were signi¢cantly increased in
COX-13=3 lung cells in comparison with WT cells
[17]. Therefore, in order to examine the potential
mechanisms of COX-2 overexpression in COX-13=3
cells, we examined constitutive COX-2 promoter ac-
tivity in each of the three cell types.
3.3. Constitutive COX-2 promoter activity is
increased in COX-13=3 cells
We examined the transcriptional regulation of the
COX-2 gene in COX-13=3 cells compared with WT
cells. To do this we transfected an 887 nucleotide
luciferase reporter construct of the 5P-£anking pro-
moter region of COX-2 into WT, COX-13=3, and
COX-23=3 cells and determined COX-2 promoter
activity in each of the cell types. As shown in Fig.
4, constitutive COX-2 promoter activity was signi¢-
cantly increased in COX-13=3 cells while promoter
activity was signi¢cantly decreased in COX-23=3
Fig. 2. Cell cycle analysis of WT, COX-13=3, and COX-23=3
cells. Cells were arrested at the G1/S boundary by culture in
DMEM with 0.5% serum for 48 h. Cell cycle was analyzed as
described in Section 2 at 8 h and 24 h following stimulation of
quiescent cells with 10% serum. (A) Pro¢les of £ow cytometry.
(B) Percentage of cells in S-phase is plotted. b, WT cells ;
F, COX-13=3 cells ; R, COX-23=3 cells. Data shown are repre-
sentative of two independent experiments.Fig. 1. Growth kinetics analysis of WT, COX-13=3, and COX-
23=3 cells. Viable cellular growth of WT, COX-13=3, and
COX-23=3 cells was evaluated by MTT assay as described in
Section 2. Data shown are representative of three independent
experiments and means of triplicate determinations. Error bars
indicate S.E. b, WT cells ; F, COX-13=3 cells ; R, COX23=3
cells. * indicates signi¢cant di¡erences from WT at P6 0.05.
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cells when compared with WT cells. These results
clearly show that when COX-1 is absent, constitutive
COX-2 transcriptional activity is signi¢cantly en-
hanced.
3.4. COX-2 promoter activity is suppressed by
deletion of a region containing the NF-UB element
To identify the transcriptional factors involved in
the regulation of COX-2 promoter activity, a dele-
tion series of COX-2 promoter-luciferase constructs
were designed. The 5P-£anking region of mouse
COX-2 gene contains putative transcriptional re-
sponse elements: NF-UB (3401 to 3393), SP-1
(3239 to 3234), AP-2 (3215 to 3208 and 150 to
3142), NF-IL6 (3138 to 3130), and CRE (356 to
348) [23,24]. A 5P deletion series of COX-2 pro-
moter-luciferase reporter constructs covering the re-
gion from 3887 to 3130 (see Fig. 5) was transfected
into COX-13=3 cells. As shown in Fig. 5, when the
COX-2 promoter region containing the NF-UB ele-
ment was deleted, luciferase activity decreased by
approx. 40%. When additional promoter regions
containing the SP-1, AP-2, and NF-IL-6 element
were deleted, there was little further inhibition of
COX-2 promoter activity (Fig. 5). These results in-
dicate the possible involvement of NF-UB in the reg-
ulation of constitutive COX-2 promoter activity in
Fig. 4. Functional activity of the COX-2 promoter fused to a
luciferase reporter gene in WT, COX-13=3, and COX23=3 cells.
A plasmid in which the 887 nucleotides of the 5P-£anking pro-
moter region of COX-2 gene were fused to the luciferase re-
porter was transfected into WT, COX-13=3, and COX-23=3
cells. Luciferase activity of the cell lysate was measured as a
function of promoter activity. Percent luciferase activity relative
to the activity measured in WT cells is shown. Data are mean-
s þ S.E. of triplicates in ¢ve independent experiments. * indi-
cates signi¢cant di¡erences at P6 0.05. Details of transfection,
harvesting, and luciferase assays are described in Section 2.
Fig. 5. Deletion constructs of COX-2 promoter fused to luciferase expression vectors and transfection analysis in COX-13=3 cells. Pu-
tative consensus transcription elements in the 5P-£anking promoter region of COX-2 gene are shown at the top of the left column.
Each deleted promoter fragment was inserted into a luciferase expression vector. Numbers at the left indicate distance in base pairs
from the transcription initiation site. Plasmids containing promoter fragments of various length were transfected into COX-13=3 cells
and luciferase activity was measured. Values are relative activity to the activity measured in cells transfected with plasmids containing
an 887 bp promoter fragment. Data are means of triplicates and error bars indicate S.E.
Fig. 3. Western blotting of COX-2 in WT, COX-13=3, and
COX-23=3 cells. Protein was extracted from WT, COX-13=3,
and COX-23=3 cells and analyzed by Western blotting using
anti-COX-2 antibody as described in Section 2.
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COX-13=3 cells. When a 130 nucleotide reporter
construct was transfected, approx. 50% relative lucif-
erase activity was observed. This COX-2 promoter
activity might be mediated by the CRE element lo-
cated at 356 to 348. The involvement of the CRE
element in the regulation of COX-2 expression was
previously reported in mouse [25] and human [26,27].
3.5. Activated NF-UB levels are proportional to
constitutive levels of COX-2 promoter activity
in COX-13=3 cells
In order to assess the potential role of NF-UB in
the regulation of COX-2 transcription in COX-13=3
cells, we prepared double-stranded oligonucleotide
probes containing the NF-UB transcriptional ele-
ment. Electrophoretic mobility shift assay (EMSA)
and supershift EMSA using antiserum speci¢c for
the p50 and p65 subunits of the NF-UB complex
were carried out using nuclear extracts from WT,
COX-13=3, and COX-23=3 cells. As shown in Fig.
6, when the NF-UB probe was incubated with nu-
clear extracts from each cell type, NF-UB binding
complexes were observed in all cases (lanes 2, 6,
and 10). However, complexes obtained with COX-
13=3 nuclear extracts showed a signi¢cantly greater
amount of shifted signal compared with WT or
COX-23=3 nuclear extracts that exhibited intermedi-
ate and trace binding, respectively. The di¡erences in
the ability of nuclear extracts from WT, COX-13=3,
and COX-23=3 cells to bind to NF-UB correlate well
with the corresponding COX-2 promoter activity
shown in Fig. 4. This speci¢c binding was completely
inhibited by unlabeled oligonucleotide competitor
identical to the probe (lanes 5, 9, and 13). NF-UB
binding complexes could be supershifted by antise-
rum speci¢c for p50 (lanes 3, 7, and 11). While anti-
serum speci¢c for p65 failed to induce a supershift
(lanes 4, 8, and 12), the possibility that the antibody
recognizes an epitope that is concealed by DNA
binding could account for the lack of a supershift.
We carried out EMSA using oligonucleotide probes
containing the AP-1 or AP-2 transcriptional element;
however, no binding complexes were observed (data
not shown).
3.6. NF-UB decoy ODNs inhibit COX-2 promoter
activity
In order to further determine that NF-UB plays a
role in regulating COX-2 expression, we examined
the e¡ect of NF-UB decoy ODNs on COX-2 pro-
Fig. 6. Electrophoretic mobility shift assay targeting the NF-UB element. An oligonucleotide probe containing the NF-UB transcription
element was incubated with the 10 Wg of nuclear extracts from WT, COX-13=3, and COX-23=3 cells (lanes 2, 6, and 10). For super-
shift assay, anti-NF-UB p50 (lanes 3, 7, and 11) or anti-NF-UB p65 (lanes 4, 8, and 12) antibody was incubated together. Unlabeled
oligonucleotide identical to the probe was added for the competition analysis (lanes 5, 9, 13). Lane 1 was a control run without the
nuclear extract. Data shown are representative of three independent experiments.
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moter activity. To do this, an 887 nucleotide lucifer-
ase construct of the COX-2 promoter region was
transfected into COX-13=3 cells and luciferase activ-
ity was measured in the absence or presence of NF-
UB decoy or scrambled ODNs. As shown in Fig. 7,
addition of NF-UB decoy ODNs suppressed lucifer-
ase activity by approx. 40%, whereas scrambled
ODNs had no signi¢cant e¡ect. The inhibitory e¡ect
of the NF-UB decoy ODNs was consistent with that
of deletion of a region containing the NF-UB element
(see Fig. 5). These results clearly demonstrate that
NF-UB plays a role in the transcriptional regulation
of the constitutive COX-2 expression in cells that do
not express COX-1.
In the present study, we demonstrate that consti-
tutive COX-2 expression is transcriptionally en-
hanced in COX-1 de¢cient cells and that elevated
levels of activated NF-UB are involved in the ob-
served upregulation of COX-2 expression in these
cells. Previous studies demonstrated the involvement
of NF-UB in cytokine-dependent induction of COX-2
expression in both mouse and human cells [24,28^
30]. Thus in one sense, the deletion of COX-1 leads
to increased levels of active NF-UB which would also
be expected in response to a variety of cytokines.
However, the e¡ect of COX-1 de¢ciency on NF-UB
activation appears to be constitutive in contrast to
the transient e¡ects of cytokines on NF-UB activa-
tion. These observations strongly suggest the poten-
tial for direct regulatory interactions between COX-1
and COX-2. Such interactions conceivably involve
the necessity for the expression of either or both
COX-1 mRNA/protein or involve the production of
speci¢c COX-1 products; studies to further examine
the potential direct e¡ects of COX-1 on COX-2 ex-
pression are currently underway. We will continue to
employ similar approaches in COX isoenzyme de¢-
cient cells, such as the transfection of the COX-1
promoter into COX-2 expressing cells, in order to
determine whether the expression of COX-2 has
any modulatory e¡ects on COX-1 expression. Such
studies will provide more important insights into the
mechanisms by which COX isoenzyme expression is
regulated.
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